Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients is a research paper published in Journal of Antimicrobial Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 2KL2TR001856-06
Institutional Career Development Core
National Institutes of Health
Grant: R01AI104895
National Institutes of Health
Grant: R21AI151362
National Institutes of Health
Grant: R03AI144636
National Institutes of Health
Grant: R21AI151363
NCATS NIH HHS
Grant: KL2 TR001856
National Institutes of Health
Grant: 5R21AI151362-02
Mechanisms of cefiderocol resistance
National Institutes of Health
Grant: 1R03AI144636-01
Characterization and suppression of resistance to new CRE agents
National Institutes of Health
Grant: 5R21AI151363-02
Use of site-specific pharmacokinetics to optimize antibiotic combinations and prevent the emergence of resistance against CRE
National Institutes of Health
Grant: 5R01AI104895-04
Colistin-resistant Acinetobacter baumannii
National Center for Advancing Translational Sciences
FWCI
1.85
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals